Risk factors and management of pasireotide-associated hyperglycemia in acromegaly
Pasireotide, a multireceptor-targeted somatostatin analog with highest affinity for somatostatin receptor subtype (SST) 5, has demonstrated superio r efficacy over the SST2-preferential somatostatin analogs octreotide and lanreotide. The safety profile is similar to those of octreotide and lanreotid...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bioscientifica
2020-12-01
|
| coleção: | Endocrine Connections |
| Assuntos: | |
| Acesso em linha: | https://ec.bioscientifica.com/view/journals/ec/9/12/EC-20-0361.xml |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|